The "Product & Company Valuation" course is designed to teach a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals, or strategic development decisions in the pharma-biotech world. This introductory course is very valuable for pharma and biotech executives who are not familiar with compound and company valuations but need a thorough understanding of the valuation concepts and techniques that are commonly applied in the pharma and biotech industries. It goes beyond the number-crunching techniques of most consultants and includes difficult to define qualitative factors, which shape the risk profile of the company in question. This course optimally balances interactive lectures with practical group work exercises that are designed to help you practice the fundamental valuation tools & techniques taught throughout the day.Valuation is an inherently subjective task, which is made even more difficult in the life science industry due to its unique challenges: high attrition rates in R&D, long investment cycle, complex technologies, IP situations, etc. Therefore, traditional valuation methods are not suitable. Of particular value in this course is the “Product Valuation and Deal Structuring” module where registrants will learn the commonly used rNPV (i.e., risk-adjusted Net Present Value) method for calculating the value of a drug in development. Subsequently, you will practice how to structure a licensing deal between companies. Registrants will use an Excel-based tool designed specifically for this module, which can be taken home for future use.Topics covered in the Product & Company Valuation course include:Introduction to valuationAssessing a company prior to valuationCompany valuation and methodsProduct valuation and methodsDeal structuringThis one-day course will be held in person on June 21, 2026, in San Diego, Calif. Registration will open in early…

Advanced Business Development (ABD) is a long-running course focusing on all key aspects of transactions in the biopharma industry. This course is ideal for professionals ranging from those with limited experience (2–3 years) looking to advance their skills; and highly experienced dealmakers or executives looking to hone their skills and network with other dealmakers. Advanced Business Development incorporates lectures from experienced dealmakers, review of example models, dissection of actual deals, interaction with other participants, and live Q&A. Also, the course includes a mock negotiation scenario when each participant is a member of a deal team assigned to negotiate a transaction involving a drug in development with another team using an actual valuation and deal structuring model.This three-day course will be held in person, June 19--21, 2026, in San Diego, Calif. Registration will open in early February 2026.Have additional questions about the BIO Professional Development Program? Please email: courseshelp@bio.org Instructors (click photos to view bios)

The Business Development Fundamentals in-person course provides a foundation of the key skills that are required to execute a licensing transaction. With a focus on the biopharma industry, the course is taught by senior executives who have personal experience and expertise in transactional and intellectual property law; business development – both sell and buy sides; finance; alliance management; negotiation, and university technology transfer.   Previous attendees include professionals from many international institutions. A sample of companies include: AlkermesNIHAmerican Society of HematologyGileadAmgenMerck National Taiwan UniversityBaylor College of MedicineNovartisBluebird BiosciencesQueensland University of TechnologyBiogenPfizerChinese University of Hong KongSanofiEli LillyTakedaEvotecUS Army Medical ResearchGenentech Who should take the course? Buy or sell-side business development or alliance management professionals with limited transactional experience Individuals interested in pursuing a career in business development, tech transfer, or alliance management Entrepreneurs Individuals who want to better understand the strategic role of business development in portfolio expansion or divestitures This three-day course will be held in person, June 19--21, 2026, in San Diego, Calif., covering specific modules for each day. A case study will be distributed at the beginning of the course. Registration will open in early February 2026.Have additional questions about the BIO Professional Development Program? Please email: courseshelp@bio.org Instructors (click photos to view bios)